Test ID: PCPRO
Plasma Cell DNA Content and Proliferation, Bone Marrow
NY State Approved 
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Useful For Suggests clinical disorders or settings where the test may be helpful
Establishing a diagnosis of a plasma cell proliferative disorder
Providing prognostic information for newly diagnosed multiple myeloma and other plasma cell proliferative disorders
Assessing response to therapy and detecting disease relapse and progression in treated plasma cell proliferative disorder patients
Determining plasma cell DNA content and proliferation
Additional Tests Lists test(s) that are always performed, at an additional charge, with the initial test(s)
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| 88465 | Flow Cytometry Interp, 2-8 Markers | No, (Bill Only) | Yes |
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
See Laboratory Screening Tests for Suspected Multiple Myeloma in Special Instructions.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Flow Cytometry, DNA Cell Cycle Analysis
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Plasma Cell Proliferation, Marrow
Aliases Lists additional common names for a test, as an aid in searching
PC Proliferation
Myeloma Staging
Plasma Cell Staging
Labeling Index
PCLIP
Plasma Cell Labeling Index (PCLI)
Myeloma Staging
Plasma Cell Staging
Labeling Index
PCLIP
Plasma Cell Labeling Index (PCLI)
External
link
PDF
document
Excel
document
Word
document